Related Experiment Video
Updated: Jun 24, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
The Global Fund 2001-2006: a review of the evidence
1The Global Fund to Fight AIDS, Tuberculosis, and Malaria and University of California, San Francisco and Berkeley, USA.
Abstract:
The Global Fund to Fight AIDS, Tuberculosis, and Malaria was launched in 2002 with the goals of financing a turnaround in the fight against the three diseases and fundamentally changing the manner in which money is channeled to poor countries. This paper explores the organization's success in fulfilling that mandate over its first five years of operation, examining both its execution of the core business of raising and distributing funds on the basis of proven performance, dramatically increased financing and its realization of this innovative model. The evidence collected demonstrates that, while improvement is needed in a number of areas, the Global Fund has made rapid progress towards realizing its founding ambition and has begun to have its intended impact on global health and development.
Related Concept Videos
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Drug Control Governance: Regulatory Bodies and Their Impact
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Clinical Trials: Overview
The Evidence for Evolution

